MedPage Today on MSN
Injectable ART suppressed HIV long-term in teens
Despite injection-site reactions, teens strongly preferred injectables to daily oral optio ...
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...
Long-acting cabotegravir/rilpivirine (Cabenuva; CAB/RPV-LA) appeared superior to daily oral antiretroviral therapy (ART) in maintaining viral load suppression for ...
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in ...
Interviews in Pakistan highlight what people with HIV want from long-acting injectable antiretroviral therapy and what may ...
Cabotegravir demonstrated efficacy as a long-acting PrEP, with no new HIV cases in the PILLAR trial over 12 months. The combination of cabotegravir and rilpivirine showed high viral suppression rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results